Bicycle Therapeutics plc
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a BCYC research report →
About the company
Bicycle Therapeutics plc, founded in 2009 and based in Cambridge, UK, is a clinical-stage biopharmaceutical company. Its core mission is to create innovative therapeutic classes for diseases currently lacking effective treatments. The company's leading investigational product, BT1718, is a Bicycle Toxin Conjugate (BTC) that is undergoing Phase I/IIa clinical trials.
- CEO
- Kevin Lee
- IPO
- 2019
- Employees
- 305
- HQ
- Cambridge, GB
Price Chart
- Market Cap
- $301.87M
- P/E
- -1.38
- P/S
- 4.75
- P/B
- 0.55
- EV/EBITDA
- 1.15
- Div Yield
- 0.00%
- Gross Margin
- -11.86%
- Op Margin
- -381.75%
- Net Margin
- -344.95%
- ROE
- -35.74%
- ROIC
- -40.07%
- Revenue
- $72.59M · 105.77%
- Net Income
- $-218,960,000 · -29.54%
- EPS
- $-3.16 · -8.59%
- Op Income
- $-247,718,000
- FCF YoY
- -52.21%
- 52W High
- $9.18
- 52W Low
- $3.92
- 50D MA
- $4.44
- 200D MA
- $5.97
- Beta
- 1.54
- Avg Volume
- 455.70K
Get TickerSpark's AI analysis on BCYC
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Apr 2, 26 | Hannay Michael Charles Ferguson | sell | 1,521 |
| Apr 6, 26 | Hannay Michael Charles Ferguson | sell | 251 |
| Apr 2, 26 | Thompson Travis Alvin | sell | 799 |
| Apr 6, 26 | Thompson Travis Alvin | sell | 102 |
| Apr 2, 26 | Perry Jennifer Scott | sell | 1,038 |
| Apr 6, 26 | Perry Jennifer Scott | sell | 37 |
| Apr 6, 26 | Perry Jennifer Scott | sell | 333 |
| Apr 2, 26 | Lee Kevin | sell | 5,967 |
| Apr 6, 26 | Lee Kevin | sell | 1,716 |
| Apr 2, 26 | Skynner Michael | sell | 1,879 |
Our BCYC coverage
Recent articles, reports, and earnings notes.
No research on BCYC yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate BCYC report →Similar companies
Peers in the same neighborhood.